India to Germany: Salmeterol Export Trade Route

The India to Germany Salmeterol corridor is one of India's established pharmaceutical export routes, with 36 shipments documented worth a combined $2.4M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 95% of all export value, reflecting the consolidated nature of India's salmeterol manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $67.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during January–March, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 13.5%, placing it at rank #11 among India's top salmeterol export destinations globally.

On the import side, key buyers of Indian salmeterol in Germany include SALUTAS PHARMA GMBH, FIEGE HEALTHCARE LOGISTICS GMBH, SALUTAS PHARMA GMBH.. and 4 others. SALUTAS PHARMA GMBH is the single largest importer with 23 shipments valued at $1.7M USD.

India's salmeterol exports to Germany are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 33 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , VAMSI PHARMA PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $67.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as airflusal 25/250 mdi inhaler (fluticasone propionate 250 mcg and salmeterol xinafoate 25 mcg inhaler) and airflusal 25/250 mdi inhaler fluticasone propionate 250 mcg and salmeterol xinafoate 25 mcg inhaler 15690 pack 1x120md, suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, SALUTAS PHARMA GMBH is the largest importer with 23 shipments worth $1.7M USD — representing 72% of all salmeterol imports from India on this route. A total of 7 buyers are active on this corridor.